Aller au contenu principal
Actualités sur la santé humaine
EMA starts rolling review of Covid-19 HIPRA’s vaccine
29-03-2022
Humain
Explorer
GoodGut and Vall d'Hebron are studying the implementation of the first non-invasive diagnostic test to detect Irritable Bowel Syndrome
27-03-2022
Humain
Explorer
AEMPS authorizes phase III clinical trial of the HIPRA’s vaccine against Covid-19
25-03-2022
Humain
Explorer
The European RBDCOV project will study HIPRA’s Covid-19 vaccine in children, adolescents and immunocompromised patients
24-03-2022
Humain
Explorer
HIPRA plans to produce 400 million doses of its SARS-CoV-2 HIPRA vaccine during 2022
16-04-2021
Humain
Explorer
HIPRA takes a firm step towards human health with research and manufacture of a COVID-19 vaccine
11-12-2020
Humain
Explorer
Charger plus